{"url_path":"/fda/drug/recalls/D-0806-2026","section_key":"summary","section_title":"DRUG Recall: Baxter Healthcare Corporation — MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-08-06","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0806-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Baxter Healthcare Corporation"},"word_count":96,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0806-2026\n\n**Recalling firm:** Baxter Healthcare Corporation\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-08-06\n**Report date:** 2026-09-09\n\n## Product\nMYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.\n\n## Reason\nCGMP Deviations\n\n## Affected lots\nLot # NC188630, NC188708, NC188791, NC188845, NC188876, NC188968, Exp Date: 12/31/2027; Lot # NC193719, NC193849, Exp Date: 04/30/2028; Lot # NC194051, NC194105, Exp Date: 05/31/2028; Lot # NC195171, Exp Date: 06/30/2028.\n\n## Distribution\nUS Nationwide; Puerto Rico; and Chile."}